High Efficacy of Azacitidine plus HAG in Acute Myeloid Leukemia: An Open-Label, Single-Arm, Multi-Center, Phase 2 Study

A total of 112 AML patients were enrolled in the study. Induction therapy consisting of Azacitidine was given in combination with the HAG (Homoharringtonine, low-dose cytarabine, G-CSF) regimen.